POSC News Alert Positron Corp (POSC) 0.0019 02/15/2015 08:55
Post# of 64074
Posted On: 02/15/2015 9:55:18 AM
Positron Corp (POSC) 0.0019 $POSC
Global Preclinical Imaging Market 2015-2019 with Aspect Imaging, Bioscan, Bruker, Mediso Medical Imaging Systems, PerkinElmer, Siemens Healthcare & Thermo Fisher Scientific Dominating
M2 - Sat Jan 31, 12:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/m5vndn/global) has announced the addition of the "Global Preclinical Imaging Market 2015-2019" report to their offering. The Global Pre-clinical Imaging market to grow at a CAGR of 15.02% over the period 2014-2019. Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection of diseases. Currently the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET CT and SPECT CT are the most used imaging combinations. In vivo imaging is increasingly used in target identification, compound optimisation and pre-Phase I studies, and in the drug development process. Thus, it bridges the gap between in vitro exploratory and in vivo clinical research. The use of multi-modalities imaging systems is a major trend in the market. Also, innovation and advances in technologies to meet research needs, safety, efficacy, and potential reversibility have resulted in the involvement of multi-modalities imaging systems. According to the report, an increase in R&D in pharma companies is one of the major drivers of the market. Because of the intense competition in the market, vendors try to develop new drugs and spend huge amounts toward drug development. Further, the report states that high cost is a major challenge that the market faces. The cost required to complete preclinical studies depends on the research involved. Vendors spend huge amounts on R&D, which will have a significant effect on the company's economy. Pre-clinical imaging systems can be segmented based on the type of equipment, as mentioned below: - Micro MRI - Micro-PET - Micro-CT - PAT - SPECT - Multi-modality - Optical Imaging - Ultrasound Key Vendors - Aspect Imaging - Bioscan (Subsidiary of Trifoil Imaging) - Bruker Corporation - Mediso Medical Imaging Systems - PerkinElmer - Siemens Healthcare - Thermo Fisher Scientific Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Modality - Global Single Modality Imaging Technique Market - Global Multi-modality Imaging Technique Market - Market Segmentation by Sub-classification - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis Companies Mentioned - Aspect Imaging - Bioscan (Subsidiary of Trifoil Imaging) - Bruker Corporation - Mediso Medical Imaging Systems - PerkinElmer - Siemens Healthcare - Thermo Fisher Scientific - Agilent Technologies - Capintec - Hitachi Medical - LI-COR Biosciences - Miltenyi Biotec GMBH - Naviscan - Positron - Promega - Quintiles For more information visit http://www.researchandmarkets.com/research/m5vndn/global
A: 40.15 (+0.13), PKI: 46.30 (-0.10)
Institute for Nuclear Research of the Russian Academy of Sciences Granted U.S. Patent for Radiostrontium Production Technology Included in Licensing Agreement with Positron Corporation
PR Newswire - Tue Jan 20, 10:04AM CST
Positron Corporation (OTCBB: POSC) is pleased to announce that the United States Patent and Trademark Office (USPTO) has awarded the Institute for Nuclear Research (INR) of the Russian Academy of Sciences a patent (U.S. No. 8,929,503) for the method for producing strontium-82 (Sr-82) - a precursor to rubidium-82 (Rb-82), the leading radiopharmaceutical used in Positron Emission Tomography (PET) myocardial perfusion imaging. It is the second patent for this technology in North America included in a license agreement between INR and Positron Corporation: INR has been awarded a Canadian patent (CA 2719347) for the same technology in July 2014. The rights to this patented technology have been granted by INR to Positron Corporation. Although other licensees, from France and Russia, can sell Sr-82 produced with the patented technology, only Positron Corporation has the right to utilize the technology in North America.
Breast Imaging Technologies Market (Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound) will reach $3 Billion by 2019
M2 - Mon Dec 29, 6:01AM CST
This report studies the global Breast Imaging Technologies Market over the forecast period from 2014 to 2019. The market is expected to reach ~$3 billion by 2019, at CAGR of 8.1% from 2014 to 2019.
Global Nuclear Medicine Radioisotopes Market - Analysis And Forecasts 2014-2019
M2 - Tue Dec 09, 8:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/n7w7ss/global_nuclear) has announced the addition of the "Global Nuclear Medicine Radioisotopes Market - Analysis And Forecasts (2014-2019)" report to their offering. The global technetium-99m market is expected to grow from an estimated $6.839 Billion in 2014 to $12.295 billion in 2019, at an estimated compound annual growth rate (CAGR) of 12.47% percent and global F-18 market is expected to grow form an estimated $1.233 billion in 2014 to $2.148 billion in 2019 with a CAGR of 11.71%. Major driving factors for the growth of the market are increasing demand of SPECT analysis in radiopharmaceuticals, development of better instruments, newer computer based procedures for image analysis and display, new 99mTc labeled agents for visualizing biologically significant events, increasing demand of PET analysis in radiopharmaceuticals, increasing use in clinical applications to study psychiatric disorders. Integration of X ray tomography (CT) into SPECT has recently emerged as a brilliant diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. . However, some of the major constrains for the market are shorter half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues. Major players in the market GE Healthcare, Hologic Inc., Medix Inc., Naviscan Inc., Positron Corporation, Segami Corporation. Mergers and acquisitions of small and medium sized manufacturers to enter in overseas market is a strategy adopted by multinational players. Key Topics Covered: 1. Introduction 2. Key Findings 3. Executive Summary 4. Market Overview 5. Market Segmentation 6. Competitive Landscape 7. Company Profiles - Agfa-Gevaert N.V. - Cardiarc Ltd - Digirad Corporation - Gamma Medica Inc - Ge Healthcare - Hologic Inc. - Medx Inc - Naviscan Inc - Positron Corporation - Segami Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/n7...al_nuclear
HOLX: 30.46 (+0.21)
Breast Imaging Technologies Market will reach $3 Billion by 2019
M2 - Fri Nov 28, 5:52AM CST
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Global ESL Market 2015-2019: Key Vendors are Altiere, Displaydata, Pricer, Store Electronic Systems and Teraoka Seiko
M2 - Tue Nov 25, 4:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/9k2slf/global_esl_market) has announced the addition of the "Global ESL Market 2015-2019" report to their offering. Increased inclinations towards dynamic pricing are one of the emerging trends in this market. Retailers use various price optimization and revenue management techniques to exceed sales and increase profits. They use dynamic pricing and change product prices based on certain marketing strategies and market demand for products. According to the report, one of the major driving forces behind the success of ESLs is the return on investment they offer to retailers. It is estimated that retailers will get their full return on the investment they make on ESLs within 18 to 24 months from the implementation of these labels. Further, the report states that ESL vendors are witnessing a decline in their profit margins owing to the rise in prices of raw materials and increased competition among vendors. The new vendors are focused more on end-user requirements and are developing ESL solutions based on these requirements, which makes them a preferred choice for global vendors. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Global ESL Market Penetration 08. Market Segmentation by Retail Store Type 09. Market Segmentation by Wireless Solution 10. Market Segmentation by Distribution Channel 11. Geographical Segmentation 12. Impact of New Technologies in Retail 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 21. Key Vendor Analysis 22. Other Reports in this Series Companies Mentioned: - Advantech US - Altiere - CEST - Displaydata - E Ink - ELTRADE - Herbert Retail - ILID - LG Innotek - Mirador Marketing - NZ Electronic Shelf Labelling - Opticon - Positron - PriceWizard - Pricer - Samsung ElectroMechanics - Store Electronic Systems - Tagnetics - Teraoka Seiko - Toshiba Global Commerce Solutions - UNO ESL - Wincor Nixdorf - Wuxi Wei Feng Technology - imagotag For more information visit http://www.researchandmarkets.com/research/9k...esl_market
Global Diagnostic Imaging Market - Trends & Forecast to 2020 for the $35 Billion Industry
M2 - Thu Nov 20, 6:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/6z2l7f/global_diagnostic) has announced the addition of the "Global Diagnostic Imaging Market - Trends & Forecast to 2020" report to their offering. Diagnostic imaging market is estimated to grow at a steady CAGR of more than 5% from 2014 to 2020 to reach a market size of more than $35 billion by the end of 2020 Some of the major factors such as increasing applications of diagnostic procedures, growing awareness about early disease diagnosis among people in the emerging markets, high incidence/prevalence of diseases such as cancer, cardiovascular and neurological disorders, favorable investments in emerging markets, and the increasing research activities across the globe are boosting the market growth. However, the high cost of diagnostic imaging systems, risk of radiation exposure, and meager healthcare insurance coverage for diagnostic procedures, shortage of helium for MRI systems, and saturated markets are hindering the market growth. In this report the diagnostic imaging technologies market is segmented by various modalities such as Computed Tomography (CT) scanners, Nuclear Imaging (NI) equipment, Magnetic Resonance Imaging (MRI) systems, Ultrasound scanners and X-ray devices. X-ray devices segment commanded the largest share in 2013 and is expected to grow strong from 2014 to 2020. Among the diagnostic imaging techniques, X-ray is the most widely used modality with more than 100 million X-ray exams per year followed by MRI, PET, SPECT, CT and nuclear medicine. However the CT scan systems market is expected to register the highest CAGR during the forecast period. The growth is mainly attributed to rising geriatric global population base, increasing incidence rates of target diseases such as cardiovascular diseases, cancer, tuberculosis and oral diseases. Scope of the Report Global Diagnostic Imaging Technologies Market by Products - X-ray devices - Stationary devices - Mobile devices - Handheld devices - Portable devices - Computed Tomography (CT) scanners - Stationary CT - Portable CT - Nuclear Imaging (NI) systems - Single Photon-Emission Computed Tomography (SPECT) - Positron Emission Tomography (PET) - Hybrid - Hybrid SPECT - Hybrid PET - Magnetic Resonance Imaging (MRI) systems - Open Systems - Close Systems - Standup/ Sitting Systems - Ultrasound scanners - Trolley/ Cart based scanners - Compact/ Portable scanners Global Diagnostic Imaging Technologies Market by Applications - Oncology - Cardiovascular diseases - Abdominal imaging - Neurological disorders - Orthopedic disorders - Lungs disorder - Others Companies Mentioned - Carestream Health, Inc. - Esaote S.P.A - GE Healthcare - Hitachi Medical Corporation - Hologic, Inc - Philips Healthcare - Samsung Medison - Shimadzu Corporation - Siemens Healthcare - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/6z...diagnostic
HOLX: 30.46 (+0.21)
Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging...) - Global Forecasts to 2019
PR Newswire - Wed Oct 29, 4:00PM CDT
The global breast imaging technologies market is estimated to grow at a CAGR of 8.1% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, and the U.K.) hold larger shares in the breast imaging technologies market, the Asia-Pacific region is expected to grow at the highest CAGR of 10.2% in the forecast period. The growth of the breast imaging technologies market is driven by factors such as public and private initiatives to increase awareness about early breast cancer screening, technological developments, growing demand for the use of minimal or negligible doses of radiation, and increasingly aging population. However, factors such as side effects of radiation exposure and high installation cost of breast imaging systems are restraining the growth of this market. Moreover, emerging economies such as India and China are creating growth opportunities for the breast imaging technologies market in these regions.
SOFIE BIOSCIENCES receives $1.5M NCI Phase II SBIR
PR Newswire - Thu Oct 16, 8:03AM CDT
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute (NCI) has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years. This contract will support the further development of SOFIE's family of proprietary imaging probes, known as [18F]FAC, that measure the enzyme, dCK, which controls the rate of DNA production through the salvage pathway. Cancer drugs, like gemcitabine and others, use dCK to convert the drug into a pharmacologically active product that blocks the high rates of DNA replication for growth of malignant cells. One of SOFIE's objectives with [18F]FAC is to use PET imaging to allow physicians to search throughout the body for tumors that will respond to drugs that target dCK, thus enabling more patient-specific treatment selection.
Global Breast Imaging Technologies Market to 2019
M2 - Thu Oct 16, 3:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jns6bn/breast_imaging) has announced the addition of the "Breast Imaging Technologies Market - Global Forecasts to 2019" report to their offering. The global breast imaging market holds a significant share of the medical device industry owing to rising awareness about the early screening of breast cancer. Though digital Mammography is the gold standard in the current breast imaging market, modalities such as breast MRI Scans, breast ultrasound and CTs are expected to drastically improve the breast Imaging Market scenario. This research analysis provides, a detailed information on breast imaging technological advancements in breast cancer diagnosis. This research report identifies and evaluates key advancements of breast screening modalities in development and approval stages. Patent analysis, investor analysis and investment opportunity evaluation along with multi-level criteria technology benchmarking are assessed within the breast imaging sector. Strategic recommendations for technology stakeholders are elaborately discussed in this research service. The global breast imaging market is estimated to grow at a CAGR of 8.1% in the forecast period. Global rise in the incidences and prevalence of breast cancer cases, rapid growth in aging population, development of advanced breast imaging technologies, and increasing awareness about early breast cancer screening are some of the key factors that are fueling the growth of the market. However, side effects of radiation dosage during breast imaging procedures, high installation cost of this systems, and false cancer diagnosis are some of the key factors hampering the growth of this market. Furthermore, stringent regulatory approvals for new technologies and government pressure to reduce the usage of radiation dose are some of the key challenges faced by market players. The emerging markets including China and India have become attractive for companies engaged in the development and marketing of the breast imaging technologies. Rising breast cancer awareness, government initiatives to increasing awareness about women healthcare, rising incidences of breast cancer, and increasing government investments in this technologies are the key factors propelling the demand of the this technologies in the emerging markets. In 2013, Hologic, Inc. (U.S.) held the leading position in the global mammography market. Over the past three years, the company adopted expansion of its R&D capabilities, new product launches, and strategic partnerships/agreements as its key business strategies to ensure its dominant position in this market. In addition, GE Healthcare (U.K.), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), SonoCine, Inc. (U.S.), and Toshiba Corporation (Japan) are some other key players in the global mammography market. Scope of the Report By Type - Ionizing Breast Imaging Technologies - Analog Mammography - Full-Field Digital Mammography - 3D Breast Tomosynthesis - Positron Emission Tomography/Computed Tomography (PET/CT) - Molecular Breast Imaging (MBI) - Cone Beam Computed Tomography (CBCT) - Positron Emission Mammography (PEM) - Non-ionizing Breast Imaging Technologies - Breast MRI - Breast Ultrasound - Optical Imaging - Whole Breast Ultrasound - Breast Thermography Companies Mentioned - Aurora Imaging Technology, Inc. - Dilon Technologies, Inc. - Dune Medical Devices - Gamma Medica, Inc. - Ge Healthcare (Apart of General Electric Company) - Hologic, Inc. - Philips Healthcare (A Part of Konninklijke Philips N.V.) - Siemens Healthcare (A Part of Siemens AG) - Sonocine, Inc. - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/jn...st_imaging
GE: 25.15 (+0.26), HOLX: 30.46 (+0.21)
Nuclear Medicine Imaging Equipment Market 2014-2020: SPECT Systems and PET Scanners- Global Strategic Business Report
M2 - Thu Sep 18, 3:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4nhk5/nuclear_medicine) has announced the addition of the "Nuclear Medicine Imaging Equipment - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Nuclear Medicine Imaging Equipment in US$ Million by the following Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and PET Scanners (Includes PET and PET/CT systems). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 31 companies including many key and niche players such as: - Digirad Corp. - GE Healthcare Plc - Mediso Medical Imaging Systems - Philips Healthcare - Positron Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview And Outlook 2. Market Trends And Issues 3. Global Medical Imaging Market An Overview 4. Cancer A Global Concern 5. Nuclear Medicine An Insight 6. Nuclear Medicine Imaging Equipment 7. Research And Development In The Recent Past 8. Product Innovations/Introductions 9. Recent Industry Activity 10. Focus On Select Global Player 11. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 31 (including Divisions/Subsidiaries 35) - The United States (18) - Canada (2) - Japan (2) Europe (9) - Germany (2) - The United Kingdom (2) - Italy (2) - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (4) For more information visit http://www.researchandmarkets.com/research/w4...r_medicine
Breast Imaging Technologies Market worth $3 Billion by 2019 - New Research Report by MarketsandMarkets
PRWeb - Sat Sep 13, 8:10PM CDT
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Telik Receives $1.5 Million National Cancer Institute Contract to Develop Novel Antibody-based PET Imaging Agent for Pancreatic Cancer
PR Newswire - Mon Aug 25, 8:30AM CDT
Telik, Inc. (OTCQB: TELK), a clinical stage oncology drug development company that merged with MabVax Therapeutics, Inc. on July 8, 2014, announced today it has received a $1.5 million contract for the Phase 2 portion of a Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI). The contract is intended to support a major portion of the preclinical work being conducted by MabVax, together with its collaboration partner, Memorial Sloan-Kettering Cancer Center (MSKCC) to develop a novel Positron Emission Tomography (PET) imaging agent for detection and assessment of pancreatic cancer.
PET Imaging Systems Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
PRWeb - Fri Aug 22, 8:05AM CDT
Positron emission tomography (PET) is a functional three dimensional imaging technique based on detection of photons originating from the destruction of emitted positrons with electrons from surrounding tissue. The imaging system produces a three-dimensional image of functional processes in the body. PET involves labeling of biomolecules with positron emitters also known as neutron deficient nuclei. As such, the whole body distribution of positron-emitting biomarkers in the whole body can be imaged with high sensitivity with the use of PET imaging system. Three-dimensional images of tracer concentration within the body are then constructed by computer analysis making PET imaging ideal for understanding biological events and biodistribution of radio labeled drugs non-invasively in animals. Though medical imaging is dominated by anatomical imaging such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (US), functional imaging modalities including positron emission tomography (PET) have been demonstrated to be of particular value in a number of disease staging and follow-up regimens. Positron Emission Tomography (PET) uses short-lived radionuclides to produce high definition 3D images of functional processes in vivo.
Breast Imaging Technologies Market Worth $3 Billion by 2019 - New Report by MarketsandMarkets
PRWeb - Mon Aug 18, 7:07AM CDT
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Global Positron Emission Tomography Market: Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
PRWeb - Sun Aug 10, 8:01AM CDT
Positron emission tomography (PET) is a nuclear medicine imaging procedure that is used to monitor various internal body organs and tissues in order to identify certain disease conditions. PET imaging procedure provides a better insight about the working condition of organs and tissues, size, shape and position. PET is most widely used by oncologists in order to diagnose various types of cancer; neurologists in order to diagnose neurological disorders and cardiologists in order to diagnose cardiovascular diseases. Ongoing developments in this area are likely to begin its use in other specialties as well. This is also performed in order to assess the progress of the treatment of certain diseases. This procedure is different from magnetic resonance imaging (MRI) and computed tomography (CT) as they only show the tissue structure and blood flow to and from organs. This imaging procedure is also being used in combination with other diagnostic technologies such as CT with an aim to provide more precise information about various neurological, cardiovascular and cancer diseases.
Breast Imaging Technologies Market worth $3 Billion by 2019
M2 - Mon Aug 04, 3:17AM CDT
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019
M2 - Mon Jul 21, 3:08AM CDT
Report Description
Global Cytogenetics Report 2014 - Technologies, Markets and Companies to 2023
M2 - Fri Jul 18, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bc7wtb/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering. The report includes summary profiles of 67 companies relevant to cytogenetics along with their 74 collaborations. Companies developing innovative technologies as well as those supplying equipment/services/reagents are identified.The report text is supplemented with 27 Tables and 9 figures. Selected 200 references are included in the bibliography. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information visit http://www.researchandmarkets.com/research/bc...togenetics Source: Jain PharmaBiotech
Global Preclinical Imaging Market 2015-2019 with Aspect Imaging, Bioscan, Bruker, Mediso Medical Imaging Systems, PerkinElmer, Siemens Healthcare & Thermo Fisher Scientific Dominating
M2 - Sat Jan 31, 12:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/m5vndn/global) has announced the addition of the "Global Preclinical Imaging Market 2015-2019" report to their offering. The Global Pre-clinical Imaging market to grow at a CAGR of 15.02% over the period 2014-2019. Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection of diseases. Currently the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET CT and SPECT CT are the most used imaging combinations. In vivo imaging is increasingly used in target identification, compound optimisation and pre-Phase I studies, and in the drug development process. Thus, it bridges the gap between in vitro exploratory and in vivo clinical research. The use of multi-modalities imaging systems is a major trend in the market. Also, innovation and advances in technologies to meet research needs, safety, efficacy, and potential reversibility have resulted in the involvement of multi-modalities imaging systems. According to the report, an increase in R&D in pharma companies is one of the major drivers of the market. Because of the intense competition in the market, vendors try to develop new drugs and spend huge amounts toward drug development. Further, the report states that high cost is a major challenge that the market faces. The cost required to complete preclinical studies depends on the research involved. Vendors spend huge amounts on R&D, which will have a significant effect on the company's economy. Pre-clinical imaging systems can be segmented based on the type of equipment, as mentioned below: - Micro MRI - Micro-PET - Micro-CT - PAT - SPECT - Multi-modality - Optical Imaging - Ultrasound Key Vendors - Aspect Imaging - Bioscan (Subsidiary of Trifoil Imaging) - Bruker Corporation - Mediso Medical Imaging Systems - PerkinElmer - Siemens Healthcare - Thermo Fisher Scientific Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Modality - Global Single Modality Imaging Technique Market - Global Multi-modality Imaging Technique Market - Market Segmentation by Sub-classification - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis Companies Mentioned - Aspect Imaging - Bioscan (Subsidiary of Trifoil Imaging) - Bruker Corporation - Mediso Medical Imaging Systems - PerkinElmer - Siemens Healthcare - Thermo Fisher Scientific - Agilent Technologies - Capintec - Hitachi Medical - LI-COR Biosciences - Miltenyi Biotec GMBH - Naviscan - Positron - Promega - Quintiles For more information visit http://www.researchandmarkets.com/research/m5vndn/global
A: 40.15 (+0.13), PKI: 46.30 (-0.10)
Institute for Nuclear Research of the Russian Academy of Sciences Granted U.S. Patent for Radiostrontium Production Technology Included in Licensing Agreement with Positron Corporation
PR Newswire - Tue Jan 20, 10:04AM CST
Positron Corporation (OTCBB: POSC) is pleased to announce that the United States Patent and Trademark Office (USPTO) has awarded the Institute for Nuclear Research (INR) of the Russian Academy of Sciences a patent (U.S. No. 8,929,503) for the method for producing strontium-82 (Sr-82) - a precursor to rubidium-82 (Rb-82), the leading radiopharmaceutical used in Positron Emission Tomography (PET) myocardial perfusion imaging. It is the second patent for this technology in North America included in a license agreement between INR and Positron Corporation: INR has been awarded a Canadian patent (CA 2719347) for the same technology in July 2014. The rights to this patented technology have been granted by INR to Positron Corporation. Although other licensees, from France and Russia, can sell Sr-82 produced with the patented technology, only Positron Corporation has the right to utilize the technology in North America.
Breast Imaging Technologies Market (Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound) will reach $3 Billion by 2019
M2 - Mon Dec 29, 6:01AM CST
This report studies the global Breast Imaging Technologies Market over the forecast period from 2014 to 2019. The market is expected to reach ~$3 billion by 2019, at CAGR of 8.1% from 2014 to 2019.
Global Nuclear Medicine Radioisotopes Market - Analysis And Forecasts 2014-2019
M2 - Tue Dec 09, 8:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/n7w7ss/global_nuclear) has announced the addition of the "Global Nuclear Medicine Radioisotopes Market - Analysis And Forecasts (2014-2019)" report to their offering. The global technetium-99m market is expected to grow from an estimated $6.839 Billion in 2014 to $12.295 billion in 2019, at an estimated compound annual growth rate (CAGR) of 12.47% percent and global F-18 market is expected to grow form an estimated $1.233 billion in 2014 to $2.148 billion in 2019 with a CAGR of 11.71%. Major driving factors for the growth of the market are increasing demand of SPECT analysis in radiopharmaceuticals, development of better instruments, newer computer based procedures for image analysis and display, new 99mTc labeled agents for visualizing biologically significant events, increasing demand of PET analysis in radiopharmaceuticals, increasing use in clinical applications to study psychiatric disorders. Integration of X ray tomography (CT) into SPECT has recently emerged as a brilliant diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. . However, some of the major constrains for the market are shorter half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues. Major players in the market GE Healthcare, Hologic Inc., Medix Inc., Naviscan Inc., Positron Corporation, Segami Corporation. Mergers and acquisitions of small and medium sized manufacturers to enter in overseas market is a strategy adopted by multinational players. Key Topics Covered: 1. Introduction 2. Key Findings 3. Executive Summary 4. Market Overview 5. Market Segmentation 6. Competitive Landscape 7. Company Profiles - Agfa-Gevaert N.V. - Cardiarc Ltd - Digirad Corporation - Gamma Medica Inc - Ge Healthcare - Hologic Inc. - Medx Inc - Naviscan Inc - Positron Corporation - Segami Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/n7...al_nuclear
HOLX: 30.46 (+0.21)
Breast Imaging Technologies Market will reach $3 Billion by 2019
M2 - Fri Nov 28, 5:52AM CST
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Global ESL Market 2015-2019: Key Vendors are Altiere, Displaydata, Pricer, Store Electronic Systems and Teraoka Seiko
M2 - Tue Nov 25, 4:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/9k2slf/global_esl_market) has announced the addition of the "Global ESL Market 2015-2019" report to their offering. Increased inclinations towards dynamic pricing are one of the emerging trends in this market. Retailers use various price optimization and revenue management techniques to exceed sales and increase profits. They use dynamic pricing and change product prices based on certain marketing strategies and market demand for products. According to the report, one of the major driving forces behind the success of ESLs is the return on investment they offer to retailers. It is estimated that retailers will get their full return on the investment they make on ESLs within 18 to 24 months from the implementation of these labels. Further, the report states that ESL vendors are witnessing a decline in their profit margins owing to the rise in prices of raw materials and increased competition among vendors. The new vendors are focused more on end-user requirements and are developing ESL solutions based on these requirements, which makes them a preferred choice for global vendors. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Global ESL Market Penetration 08. Market Segmentation by Retail Store Type 09. Market Segmentation by Wireless Solution 10. Market Segmentation by Distribution Channel 11. Geographical Segmentation 12. Impact of New Technologies in Retail 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 21. Key Vendor Analysis 22. Other Reports in this Series Companies Mentioned: - Advantech US - Altiere - CEST - Displaydata - E Ink - ELTRADE - Herbert Retail - ILID - LG Innotek - Mirador Marketing - NZ Electronic Shelf Labelling - Opticon - Positron - PriceWizard - Pricer - Samsung ElectroMechanics - Store Electronic Systems - Tagnetics - Teraoka Seiko - Toshiba Global Commerce Solutions - UNO ESL - Wincor Nixdorf - Wuxi Wei Feng Technology - imagotag For more information visit http://www.researchandmarkets.com/research/9k...esl_market
Global Diagnostic Imaging Market - Trends & Forecast to 2020 for the $35 Billion Industry
M2 - Thu Nov 20, 6:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/6z2l7f/global_diagnostic) has announced the addition of the "Global Diagnostic Imaging Market - Trends & Forecast to 2020" report to their offering. Diagnostic imaging market is estimated to grow at a steady CAGR of more than 5% from 2014 to 2020 to reach a market size of more than $35 billion by the end of 2020 Some of the major factors such as increasing applications of diagnostic procedures, growing awareness about early disease diagnosis among people in the emerging markets, high incidence/prevalence of diseases such as cancer, cardiovascular and neurological disorders, favorable investments in emerging markets, and the increasing research activities across the globe are boosting the market growth. However, the high cost of diagnostic imaging systems, risk of radiation exposure, and meager healthcare insurance coverage for diagnostic procedures, shortage of helium for MRI systems, and saturated markets are hindering the market growth. In this report the diagnostic imaging technologies market is segmented by various modalities such as Computed Tomography (CT) scanners, Nuclear Imaging (NI) equipment, Magnetic Resonance Imaging (MRI) systems, Ultrasound scanners and X-ray devices. X-ray devices segment commanded the largest share in 2013 and is expected to grow strong from 2014 to 2020. Among the diagnostic imaging techniques, X-ray is the most widely used modality with more than 100 million X-ray exams per year followed by MRI, PET, SPECT, CT and nuclear medicine. However the CT scan systems market is expected to register the highest CAGR during the forecast period. The growth is mainly attributed to rising geriatric global population base, increasing incidence rates of target diseases such as cardiovascular diseases, cancer, tuberculosis and oral diseases. Scope of the Report Global Diagnostic Imaging Technologies Market by Products - X-ray devices - Stationary devices - Mobile devices - Handheld devices - Portable devices - Computed Tomography (CT) scanners - Stationary CT - Portable CT - Nuclear Imaging (NI) systems - Single Photon-Emission Computed Tomography (SPECT) - Positron Emission Tomography (PET) - Hybrid - Hybrid SPECT - Hybrid PET - Magnetic Resonance Imaging (MRI) systems - Open Systems - Close Systems - Standup/ Sitting Systems - Ultrasound scanners - Trolley/ Cart based scanners - Compact/ Portable scanners Global Diagnostic Imaging Technologies Market by Applications - Oncology - Cardiovascular diseases - Abdominal imaging - Neurological disorders - Orthopedic disorders - Lungs disorder - Others Companies Mentioned - Carestream Health, Inc. - Esaote S.P.A - GE Healthcare - Hitachi Medical Corporation - Hologic, Inc - Philips Healthcare - Samsung Medison - Shimadzu Corporation - Siemens Healthcare - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/6z...diagnostic
HOLX: 30.46 (+0.21)
Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging...) - Global Forecasts to 2019
PR Newswire - Wed Oct 29, 4:00PM CDT
The global breast imaging technologies market is estimated to grow at a CAGR of 8.1% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, and the U.K.) hold larger shares in the breast imaging technologies market, the Asia-Pacific region is expected to grow at the highest CAGR of 10.2% in the forecast period. The growth of the breast imaging technologies market is driven by factors such as public and private initiatives to increase awareness about early breast cancer screening, technological developments, growing demand for the use of minimal or negligible doses of radiation, and increasingly aging population. However, factors such as side effects of radiation exposure and high installation cost of breast imaging systems are restraining the growth of this market. Moreover, emerging economies such as India and China are creating growth opportunities for the breast imaging technologies market in these regions.
SOFIE BIOSCIENCES receives $1.5M NCI Phase II SBIR
PR Newswire - Thu Oct 16, 8:03AM CDT
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute (NCI) has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years. This contract will support the further development of SOFIE's family of proprietary imaging probes, known as [18F]FAC, that measure the enzyme, dCK, which controls the rate of DNA production through the salvage pathway. Cancer drugs, like gemcitabine and others, use dCK to convert the drug into a pharmacologically active product that blocks the high rates of DNA replication for growth of malignant cells. One of SOFIE's objectives with [18F]FAC is to use PET imaging to allow physicians to search throughout the body for tumors that will respond to drugs that target dCK, thus enabling more patient-specific treatment selection.
Global Breast Imaging Technologies Market to 2019
M2 - Thu Oct 16, 3:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jns6bn/breast_imaging) has announced the addition of the "Breast Imaging Technologies Market - Global Forecasts to 2019" report to their offering. The global breast imaging market holds a significant share of the medical device industry owing to rising awareness about the early screening of breast cancer. Though digital Mammography is the gold standard in the current breast imaging market, modalities such as breast MRI Scans, breast ultrasound and CTs are expected to drastically improve the breast Imaging Market scenario. This research analysis provides, a detailed information on breast imaging technological advancements in breast cancer diagnosis. This research report identifies and evaluates key advancements of breast screening modalities in development and approval stages. Patent analysis, investor analysis and investment opportunity evaluation along with multi-level criteria technology benchmarking are assessed within the breast imaging sector. Strategic recommendations for technology stakeholders are elaborately discussed in this research service. The global breast imaging market is estimated to grow at a CAGR of 8.1% in the forecast period. Global rise in the incidences and prevalence of breast cancer cases, rapid growth in aging population, development of advanced breast imaging technologies, and increasing awareness about early breast cancer screening are some of the key factors that are fueling the growth of the market. However, side effects of radiation dosage during breast imaging procedures, high installation cost of this systems, and false cancer diagnosis are some of the key factors hampering the growth of this market. Furthermore, stringent regulatory approvals for new technologies and government pressure to reduce the usage of radiation dose are some of the key challenges faced by market players. The emerging markets including China and India have become attractive for companies engaged in the development and marketing of the breast imaging technologies. Rising breast cancer awareness, government initiatives to increasing awareness about women healthcare, rising incidences of breast cancer, and increasing government investments in this technologies are the key factors propelling the demand of the this technologies in the emerging markets. In 2013, Hologic, Inc. (U.S.) held the leading position in the global mammography market. Over the past three years, the company adopted expansion of its R&D capabilities, new product launches, and strategic partnerships/agreements as its key business strategies to ensure its dominant position in this market. In addition, GE Healthcare (U.K.), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), SonoCine, Inc. (U.S.), and Toshiba Corporation (Japan) are some other key players in the global mammography market. Scope of the Report By Type - Ionizing Breast Imaging Technologies - Analog Mammography - Full-Field Digital Mammography - 3D Breast Tomosynthesis - Positron Emission Tomography/Computed Tomography (PET/CT) - Molecular Breast Imaging (MBI) - Cone Beam Computed Tomography (CBCT) - Positron Emission Mammography (PEM) - Non-ionizing Breast Imaging Technologies - Breast MRI - Breast Ultrasound - Optical Imaging - Whole Breast Ultrasound - Breast Thermography Companies Mentioned - Aurora Imaging Technology, Inc. - Dilon Technologies, Inc. - Dune Medical Devices - Gamma Medica, Inc. - Ge Healthcare (Apart of General Electric Company) - Hologic, Inc. - Philips Healthcare (A Part of Konninklijke Philips N.V.) - Siemens Healthcare (A Part of Siemens AG) - Sonocine, Inc. - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/jn...st_imaging
GE: 25.15 (+0.26), HOLX: 30.46 (+0.21)
Nuclear Medicine Imaging Equipment Market 2014-2020: SPECT Systems and PET Scanners- Global Strategic Business Report
M2 - Thu Sep 18, 3:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4nhk5/nuclear_medicine) has announced the addition of the "Nuclear Medicine Imaging Equipment - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Nuclear Medicine Imaging Equipment in US$ Million by the following Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and PET Scanners (Includes PET and PET/CT systems). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 31 companies including many key and niche players such as: - Digirad Corp. - GE Healthcare Plc - Mediso Medical Imaging Systems - Philips Healthcare - Positron Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview And Outlook 2. Market Trends And Issues 3. Global Medical Imaging Market An Overview 4. Cancer A Global Concern 5. Nuclear Medicine An Insight 6. Nuclear Medicine Imaging Equipment 7. Research And Development In The Recent Past 8. Product Innovations/Introductions 9. Recent Industry Activity 10. Focus On Select Global Player 11. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 31 (including Divisions/Subsidiaries 35) - The United States (18) - Canada (2) - Japan (2) Europe (9) - Germany (2) - The United Kingdom (2) - Italy (2) - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (4) For more information visit http://www.researchandmarkets.com/research/w4...r_medicine
Breast Imaging Technologies Market worth $3 Billion by 2019 - New Research Report by MarketsandMarkets
PRWeb - Sat Sep 13, 8:10PM CDT
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Telik Receives $1.5 Million National Cancer Institute Contract to Develop Novel Antibody-based PET Imaging Agent for Pancreatic Cancer
PR Newswire - Mon Aug 25, 8:30AM CDT
Telik, Inc. (OTCQB: TELK), a clinical stage oncology drug development company that merged with MabVax Therapeutics, Inc. on July 8, 2014, announced today it has received a $1.5 million contract for the Phase 2 portion of a Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI). The contract is intended to support a major portion of the preclinical work being conducted by MabVax, together with its collaboration partner, Memorial Sloan-Kettering Cancer Center (MSKCC) to develop a novel Positron Emission Tomography (PET) imaging agent for detection and assessment of pancreatic cancer.
PET Imaging Systems Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
PRWeb - Fri Aug 22, 8:05AM CDT
Positron emission tomography (PET) is a functional three dimensional imaging technique based on detection of photons originating from the destruction of emitted positrons with electrons from surrounding tissue. The imaging system produces a three-dimensional image of functional processes in the body. PET involves labeling of biomolecules with positron emitters also known as neutron deficient nuclei. As such, the whole body distribution of positron-emitting biomarkers in the whole body can be imaged with high sensitivity with the use of PET imaging system. Three-dimensional images of tracer concentration within the body are then constructed by computer analysis making PET imaging ideal for understanding biological events and biodistribution of radio labeled drugs non-invasively in animals. Though medical imaging is dominated by anatomical imaging such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (US), functional imaging modalities including positron emission tomography (PET) have been demonstrated to be of particular value in a number of disease staging and follow-up regimens. Positron Emission Tomography (PET) uses short-lived radionuclides to produce high definition 3D images of functional processes in vivo.
Breast Imaging Technologies Market Worth $3 Billion by 2019 - New Report by MarketsandMarkets
PRWeb - Mon Aug 18, 7:07AM CDT
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Global Positron Emission Tomography Market: Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
PRWeb - Sun Aug 10, 8:01AM CDT
Positron emission tomography (PET) is a nuclear medicine imaging procedure that is used to monitor various internal body organs and tissues in order to identify certain disease conditions. PET imaging procedure provides a better insight about the working condition of organs and tissues, size, shape and position. PET is most widely used by oncologists in order to diagnose various types of cancer; neurologists in order to diagnose neurological disorders and cardiologists in order to diagnose cardiovascular diseases. Ongoing developments in this area are likely to begin its use in other specialties as well. This is also performed in order to assess the progress of the treatment of certain diseases. This procedure is different from magnetic resonance imaging (MRI) and computed tomography (CT) as they only show the tissue structure and blood flow to and from organs. This imaging procedure is also being used in combination with other diagnostic technologies such as CT with an aim to provide more precise information about various neurological, cardiovascular and cancer diseases.
Breast Imaging Technologies Market worth $3 Billion by 2019
M2 - Mon Aug 04, 3:17AM CDT
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019
M2 - Mon Jul 21, 3:08AM CDT
Report Description
Global Cytogenetics Report 2014 - Technologies, Markets and Companies to 2023
M2 - Fri Jul 18, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bc7wtb/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering. The report includes summary profiles of 67 companies relevant to cytogenetics along with their 74 collaborations. Companies developing innovative technologies as well as those supplying equipment/services/reagents are identified.The report text is supplemented with 27 Tables and 9 figures. Selected 200 references are included in the bibliography. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information visit http://www.researchandmarkets.com/research/bc...togenetics Source: Jain PharmaBiotech
(0)
(0)Scroll down for more posts ▼